These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21171937)

  • 1. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
    Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
    Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
    Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
    Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment and validation of an Arabic Aging Male Symptoms questionnaire in patients with androgen deficiency.
    Rabah DM; Altaweel W; Arafa MA
    Aging Male; 2011 Mar; 14(1):33-6. PubMed ID: 20828246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients].
    Taniguchi H; Kawa G; Kinoshita H; Matsuda T
    Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of androgen deficiency and replacement on prostate zonal volumes.
    Jin B; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of androgen supplementation therapy on the prostate.
    Kaufman JM
    Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients.
    Aktas BK; Gokkaya CS; Bulut S; Dinek M; Ozden C; Memis A
    Aging Male; 2011 Mar; 14(1):48-52. PubMed ID: 21087172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.
    Berkseth KE; Thirumalai A; Amory JK
    Med Clin North Am; 2016 Jul; 100(4):791-805. PubMed ID: 27235615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.
    Amano T; Imao T; Takemae K; Iwamoto T; Nakanome M
    Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
    Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
    Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratoristic strategy in late onset hypogonadism.
    Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
    Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.